Cargando…
Integrative Analysis of Proteome and Ubiquitylome Reveals Unique Features of Lysosomal and Endocytic Pathways in Gefitinib‐Resistant Non‐Small Cell Lung Cancer Cells
Non‐small cell lung cancer (NSCLC) patients carrying EGFR activating mutations treated with gefitinib, a tyrosine kinase inhibitor, will develop drug resistance. Ubiquitylation is one of major posttranslational modifications of proteins affecting the stability or function of proteins. However, the r...
Autores principales: | Li, Wang, Wang, Heyong, Yang, Yan, Zhao, Tian, Zhang, Zhixiong, Tian, Ye, Shi, Zhaomie, Peng, Xiaojun, Li, Fei, Feng, Yonghong, Zhang, Lei, Jiang, Gening, Zhang, Fan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099292/ https://www.ncbi.nlm.nih.gov/pubmed/29901268 http://dx.doi.org/10.1002/pmic.201700388 |
Ejemplares similares
-
Global analysis of HBV-mediated host proteome and ubiquitylome change in HepG2.2.15 human hepatoblastoma cell line
por: Yuan, Sen, et al.
Publicado: (2021) -
Proteome and Ubiquitylome Analyses of Maize Endoplasmic Reticulum under Heat Stress
por: Gao, Chunyan, et al.
Publicado: (2023) -
The ubiquitylome of developing cortical neurons
por: Menon, Shalini, et al.
Publicado: (2020) -
Suberoylanilide Hydroxamic Acid Treatment Reveals Crosstalks among Proteome, Ubiquitylome and Acetylome in Non-Small Cell Lung Cancer A549 Cell Line
por: Wu, Quan, et al.
Publicado: (2015) -
ERK inhibition represses gefitinib resistance in non-small cell lung cancer cells
por: Qi, Mengfan, et al.
Publicado: (2018)